DMHA Liquid

Description

DMHA Liquid is an advanced research product meticulously designed for scientific investigations in various fields, including pharmacology and physiology. This liquid formulation contains DMHA (2-aminoisoheptane), a compound that has gained interest for its potential effects on physiological parameters. This product is strictly for research purposes and is not intended for human consumption

Key Characteristics

DMHA Liquid is distinguished by its solubility and purity. The liquid formulation allows for precise dosing, while stringent quality control measures ensure its reliability in research applications.

Research Applications

Researchers and scientists can employ DMHA Liquid for a range of research areas, including studies on nasal congestion, hypotension, and pain thresholds. The liquid form offers flexibility in dosing and application, making it a valuable tool for investigating DMHA’s potential in these domains.

Research Benefits

Nasal Congestion

DMHA has been explored for its potential in alleviating nasal congestion and promoting respiratory relief. Studies have investigated its impact on nasal passages, and researchers can further explore its effects on respiratory function.

Hypotension

Some preliminary research suggests that DMHA may have hypotensive effects, which could influence blood pressure regulation. Researchers can investigate its impact on blood pressure and its potential mechanisms in preclinical models.

Pain Threshold

DMHA has also been studied for its potential impact on pain thresholds. Researchers can explore its effects on pain perception and threshold levels, contributing to our understanding of its analgesic properties.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer satisfaction is our top priority. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at support@bc9.co.

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. CHARLIER R, PHILIPPOT E. Activité pneumodilatatrice comparée, chez l’homme de trois amines aliphatiques en aérosols [Comparison of the bronchodilatory action in man of three aliphatic amines in aerosol]. Arch Int Pharmacodyn Ther. 1950 Apr 15;82(2):243-6. Undetermined Language. PMID: 15414026. [Read More]
2. FELLOWS EJ. The pharmacology of 2-amino-6-methylheptane. J Pharmacol Exp Ther. 1947 Aug;90(4):351-8. PMID: 20265812. [Read More]